Since the initial pyroptotic signals ROS and the NLRP3 inflammasome were potential targets of molecular hydrogen, and because increased tumor cell ROS could promote cancer cell death, we investigated whether treatment with hydrogen was able to boost ROS accumulation in endometrial cancer cells. The gene discussed is NLRP3; the disease is neoplasm.